Cannabis In Science & Health

A recent industry-backed survey reveals that 16% of U.S. adults use cannabis to aid sleep, making it a more popular choice than prescription sleep aids (12%) and alcohol (11%). However, it remains less common than supplements (26%) and over-the-counter (OTC) sleep aids (19%). Conducted by The Harris Poll for Green Thumb Industries, the survey highlights

Ukraine has officially registered its first medical cannabis product, with oral cannabis drops developed in Spain expected to be available in pharmacies early this year. The announcement was made by Deputy Prime Minister for European and Euro-Atlantic Integration Olha Stefanyshyna and the Patients of Ukraine Charitable Foundation on Wednesday. This development comes a year after

Researchers in Toronto are delving deeper into how cannabis enhances users’ musical experiences with a new study set to run through early 2025. Building on their 2023 findings that marijuana boosts enjoyment of music, the team has partnered with Club Lit, a downtown cannabis consumption lounge, to survey consumers in a real-world setting. The goal

Health officials in France have announced an extension of the country’s experimental medical cannabis program until July 31, 2025. Originally set to expire on December 31, 2024, the program, which began in March 2021, has been extended in order to further study the effects of medical cannabis on patients suffering from chronic diseases. The initial

The Rutgers Institute for Health, Health Care Policy, and Aging Research has been awarded a $686,376 grant from the National Institute on Drug Abuse (NIDA) to explore the therapeutic benefits of medical use and investigate potential side effects and health risks. Led by Tammy Chung, a psychiatry professor at Rutgers Health, the research aims to

In a significant move for medical cannabis research, the U.S. Food and Drug Administration (FDA) has approved a clinical trial to explore the potential benefits of smoking or vaping cannabis products to treat post-traumatic stress disorder (PTSD) among veterans. The study, which aims to provide vital insights into how cannabis can help manage PTSD symptoms,

Kentucky is taking a significant step toward launching its medical program as patient certifications open on December 1, according to WLKY. During last week’s Team Kentucky update, Gov. Andy Beshear confirmed the launch of a webpage at kymedcan.ky.gov to connect patients with over 150 authorized healthcare providers. Certified patients can begin applying for medical ID